Cargando…

Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo

BACKGROUND: Atopic dermatitis (AD) is a complex inflammatory skin condition characterized by the proliferation and activation of immune cells in skin. Isoliquiritin (ISO) is an active component purified from Glycyrrhiza glabra. This study aimed to test the therapeutic potential of ISO for AD and ver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qing, Mo, Xiumei, Lin, Ying, Liu, Junfeng, Ye, Siqi, Zhang, Yu, Fan, Xingxing, Chen, Dacan, Yan, Fenggen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577790/ https://www.ncbi.nlm.nih.gov/pubmed/36267759 http://dx.doi.org/10.21037/atm-22-3989

Ejemplares similares

MicroRNA-146a as a potential regulator involved in the pathogenesis of atopic dermatitis
por: Yan, Fenggen, et al.
Publicado: (2019)

Therapeutic Effects of Chinese Herbal Formula (PTQX) on NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions
por: Yan, Fenggen, et al.
Publicado: (2019)

Gu-Ben-Hua-Shi (AESS) formula ameliorates atopic dermatitis via regulating NLRP3 signaling pathways
por: Li, Xiong, et al.
Publicado: (2023)

Thymic function in the regulation of T cells, and molecular mechanisms underlying the modulation of cytokines and stress signaling
por: Yan, Fenggen, et al.
Publicado: (2017)

Therapeutic effect of chinese herbal medicine gu-ben-hua-shi (AESS) formula on atopic dermatitis through regulation of yes-associated protein
por: Jia, Jinjing, et al.
Publicado: (2022)

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
por: Huang, I-Hsin, et al.
Publicado: (2022)

Development and initial validation of a traditional Chinese medicine symptom-specific outcome measure: a Zheng-related atopic dermatitis symptom questionnaire (ZRADSQ)
por: Wu, Darong, et al.
Publicado: (2013)

JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
por: Szalus, Krzysztof, et al.
Publicado: (2020)

RAS‐association domain family 1A regulates the abnormal cell proliferation in psoriasis via inhibition of Yes‐associated protein
por: Jia, Jinjing, et al.
Publicado: (2021)

The first case report of kerion-type scalp mycosis caused by Aspergillus protuberus
por: Jia, Jinjing, et al.
Publicado: (2019)

The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis
por: Bao, Lei, et al.
Publicado: (2013)

Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
por: Kopalli, Spandana Rajendra, et al.
Publicado: (2022)

HPLC Method Determination of Isoliquiritin Apioside and Isoliquiritin in Rat Plasma for Application in Pharmacokinetic Study after an Oral Administration of Zhigancao Extract
por: Yang, Yan-yun, et al.
Publicado: (2012)

The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
por: Tsiogka, Aikaterini, et al.
Publicado: (2022)

The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway
por: Han, Xianwei, et al.
Publicado: (2023)

Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
por: Montilla, Ana M., et al.
Publicado: (2019)

Hybrid Membrane-Derived Nanoparticles for Isoliquiritin Enhanced Glioma Therapy
por: Shi, Wenwan, et al.
Publicado: (2022)

Inhibitory Effect of Carnosol on Phthalic Anhydride-Induced Atopic Dermatitis via Inhibition of STAT3
por: Lee, Do Yeon, et al.
Publicado: (2017)

Antifungal Activity of Isoliquiritin and Its Inhibitory Effect against Peronophythora litchi Chen through a Membrane Damage Mechanism
por: Luo, Jianjun, et al.
Publicado: (2016)

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023)

A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
por: Tampa, Mircea, et al.
Publicado: (2023)

The Inhibitory Effect of Premature Citrus unshiu Extract on Atopic Dermatitis In Vitro and In Vivo
por: Kang, Gyeoung-Jin, et al.
Publicado: (2011)

Isoliquiritin Apioside Suppresses in vitro Invasiveness and Angiogenesis of Cancer Cells and Endothelial Cells
por: Kim, Aeyung, et al.
Publicado: (2018)

Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
por: Kiely, Lisa, et al.
Publicado: (2022)

Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence
por: Kamata, Masahiro, et al.
Publicado: (2023)

The Slough of Cicadidae Periostracum Ameliorated Lichenification by Inhibiting Interleukin (IL)-22/Janus Kinase (JAK) 1/Signal Transducer and Activator of Transcription (STAT) 3 Pathway in Atopic Dermatitis
por: Park, Ganghye, et al.
Publicado: (2023)

Construction and verification of atopic dermatitis diagnostic model based on pyroptosis related biological markers using machine learning methods
por: Wu, Wenfeng, et al.
Publicado: (2023)

Inhibitory Effect of Bisdemethoxycurcumin on DNCB-Induced Atopic Dermatitis in Mice
por: Wang, Yanjie, et al.
Publicado: (2022)

T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
por: Zheng, Chunjiao, et al.
Publicado: (2023)

Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis
por: Juczynska, K., et al.
Publicado: (2017)

Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients
por: Torres, Tiago, et al.
Publicado: (2021)

Chemical Composition and Inhibitory Effect of Lentinula edodes Ethanolic Extract on Experimentally Induced Atopic Dermatitis in Vitro and in Vivo
por: Choi, Eun-Ju, et al.
Publicado: (2016)

Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis
por: Lee, Nara, et al.
Publicado: (2016)

Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
por: Morris, Gabriela M., et al.
Publicado: (2018)

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
por: Nezamololama, Novin, et al.
Publicado: (2020)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8tp1d980gshbt70r3qu7gd69gv